(Q44781179)

6 December 2017

title

What is the best treatment strategy for incidentally detected small renal masses? A decision analysis (English)

1 reference

6 December 2017

1 reference

5

Shabbir M H Alibhai

1 reference

6 December 2017

Robert Abouassaly

1

1 reference

6 December 2017

Simon Yang

series ordinal

2

1 reference

6 December 2017

Antonio Finelli

series ordinal

3

1 reference

6 December 2017

Girish S Kulkarni

series ordinal

4

1 reference

6 December 2017

publication date

13 May 2011

1 reference

6 December 2017

1 reference

6 December 2017

volume

108

1 reference

6 December 2017

issue

8 Pt 2

1 reference

6 December 2017

page(s)

E223-31

1 reference

Staging of renal cell carcinoma: past, present, and future

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Rising incidence of renal cell cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Renal cell cancer stage migration: analysis of the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Renal cryotherapy: a detailed review including a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Decision analysis and Markov modeling in urology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Delayed intervention of sporadic renal masses undergoing active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Histopathology of surgically managed renal tumors: analysis of a contemporary series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

7-year oncological outcomes after laparoscopic and open partial nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Thirty-day mortality after nephrectomy: clinical implications for informed consent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Active surveillance for selected patients with renal masses: updated results with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Complications of radical and partial nephrectomy in a large contemporary cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Laparoscopic versus open partial nephrectomy: analysis of the current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Meta-analysis of the complications of laparoscopic renal surgery: comparison of procedures and techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Complications of 2,775 urological laparoscopic procedures: 1993 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

One thousand health-related quality-of-life estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Do older men benefit from curative therapy of localized prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Laparoscopic versus open donor nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Diffusion of surgical innovation among patients with kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Laparoscopic radical nephrectomy for renal cell carcinoma: oncological outcomes at 10 years or more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Active surveillance of renal masses in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Rapid kidney function decline and mortality risk in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Cystatin C and aging success

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Guideline for management of the clinical T1 renal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

Unintended Consequences of Laparoscopic Surgery on Partial Nephrectomy for Kidney Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10115.X

10.1111/J.1464-410X.2011.10115.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference